Stroke, Vol 19, 1535-1539, Copyright © 1988 by American Heart Association
J DeLeo, P Schubert and GW Kreutzberg
We studied the xanthine derivative propentofylline (HWA 285) to determine
its protection against ischemic brain damage when administered before and
after ischemia. Transient forebrain ischemia was produced in 81 Mongolian
gerbils by occluding both carotid arteries. The necessary surgery was
performed under anesthesia with intraperitoneal pentobarbital/chloral
hydrate 2 days before occlusion. We tested the parameters delayed selective
hippocampal nerve cell damage, generation of seizures, and survival.
Determination of the dose- response relation revealed the optimal dose of
HWA 285 to be 10 mg/kg i.p. The effect of the drug on delayed selective
nerve cell damage in the hippocampus was assessed by measuring the
intensity of Nissl staining in the CA1 area by means of densitometry 4 days
after a 10- minute occlusion. Gerbils treated with HWA 285 revealed
significant protection of the CA1 neurons even when the drug was applied 1
hour after the end of the occlusion. In contrast to HWA 285, pentobarbital
provided no detectable protection of the CA1 neurons in our experimental
model when administered 1 hour after occlusion, suggesting different
mechanisms of action. After a 15-minute occlusion, all six untreated
gerbils developed convulsions and died within 2 days. Chronic (daily)
treatment of nine gerbils with HWA 285 prevented the generation of
convulsions in eight and allowed seven to survive for greater than 12 days.
ARTICLES
Protection against ischemic brain damage using propentofylline in gerbils
Max Planck Institute for Psychiatry, Department of Neuromorphology, Martinsried, Federal Republic of Germany.
This article has been cited by other articles:
![]() |
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al. Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation, May 22, 2007; 115(20): e478 - e534. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al. Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists Stroke, May 1, 2007; 38(5): 1655 - 1711. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |